文献速递主动脉疾病

切开入路与经皮入路在EVAR中的比较:30天非计划再入院和伤口并发症更高

Cutdown is Associated with Higher 30-day Unplanned Readmissions and Wound Complications than Percutaneous Access for EVAR.
PubMed 文献 · Ann Vasc Surg · 2024-04-08

基于美国外科医师学会国家手术质量改进计划血管模块2012至2021年数据,纳入14,002例择期EVAR患者,比较双侧切开、单侧切开、经皮失败转开放和完全经皮四种入路。多因素分析显示双侧切开与完全经皮相比30天非计划再入院风险升高(AOR 1.26,95%CI 1.09-1.43,P=0.001),双侧和单侧切开伤口并发症风险均显著高于经皮入路。作者认为若解剖条件允许,应优先选择经皮入路。

要点

  • 双侧切开与完全经皮相比30天非计划再入院风险升高(AOR 1.26,95%CI 1.09-1.43,P=0.001)。
  • 双侧切开伤口并发症风险显著高于经皮(AOR 4.41,95%CI 2.86-6.79,P<0.001)。
  • 单侧切开伤口并发症风险亦高于经皮(AOR 3.04,95%CI 1.46-6.32,P=0.003)。

核心结论

  • 接受切开入路行EVAR的患者与完全经皮入路相比30天再入院风险更高。
  • 若患者解剖条件允许经皮EVAR,应优先选择经皮入路。

研究设计与样本

  • 回顾性队列研究,查询美国外科医师学会国家手术质量改进计划靶向血管模块2012至2021年数据。
  • 纳入因主动脉疾病行EVAR的患者14,002例,排除所有破裂和其他急诊病例。
  • 按入路分为双侧切开(5,616例,40%)、单侧切开(849例,6%)、经皮失败转开放(146例,1%)和完全经皮(7,395例,53%)四组。
  • 主要30天结局为非计划再入院和伤口并发症,采用Fisher精确检验、卡方检验和Student t检验进行单因素分析,采用逻辑回归进行多因素分析。

主要发现

  • 30天非计划再入院率:双侧切开7.6%,单侧切开7.3%,经皮尝试转切开7.8%,完全经皮5.7%(P<0.001)。
  • 多因素分析显示,与经皮入路相比,经皮转切开再入院AOR 1.38,95%CI 0.76-2.53,P=0.29;单侧切开AOR 1.18,95%CI 0.92-1.51,P=0.20;双侧切开AOR 1.26,95%CI 1.09-1.43,P=0.001。
  • 双侧切开与经皮相比伤口并发症AOR 4.41,95%CI 2.86-6.79,P<0.001;单侧切开与经皮相比AOR 3.04,95%CI 1.46-6.32,P=0.003。

临床怎么用

  • 作者认为,若患者解剖条件允许经皮EVAR,应优先选择经皮入路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A 2023 Cochrane review showed no difference in bleeding/wound infection complications, short-term mortality and aneurysm exclusion between the percutaneous and cut-down approach for femoral access in endovascular aortic aneurysm repair (EVAR). In contrast, single-center studies have shown bilateral cutdown resulting in higher readmission rates due to higher rates of groin wound infections. Whether 30-day readmission rates vary by type of access during EVAR procedures is unknown. The goal of this study was to ascertain which femoral access approach for EVAR is associated with the lowest risk of 30-day readmission. METHODS: The Targeted Vascular Module from the American College of Surgeons National Surgical Quality Improvement Program was queried to identify patients undergoing EVAR for aortic disease from 2012-2021. All ruptures and other emergency cases were excluded. Cohorts were divided into bilateral cutdown, unilateral cutdown, failed percutaneous attempt converted to open and successful percutaneous access. The primary 30-day outcomes were unplanned readmission and wound complications. Univariate analyses were performed using the Fisher's exact test, Chi-Square test and the Student's t-test. Multivariable analysis was performed using logistic regression. RESULTS: From 2012 to 2021, 14,002 patients met study criteria. Most (7,395 [53%]) underwent completely percutaneous access, 5,616 (40%) underwent bilateral cutdown, 849 (6%) underwent unilateral cutdown, and 146 (1%) had a failed percutaneous access which was converted to open. Unplanned readmissions by access strategy included 7.6% for bilateral cutdown, 7.3% for unilateral cutdown, 7.8% for attempted percutaneous converted to cutdown, and 5.7% for completely percutaneous access (P < 0.001, Figure 1). After multivariable analysis, unplanned readmissions compared to percutaneous access yielded: percutaneous converted to cutdown adjusted odds ratio (AOR): 1.38, 95% CI [0.76-2.53], P = 0.29; unilateral cutdown AOR: 1.18, 95% CI [0.92-1.51], P = 0.20; bilateral cutdown AOR: 1.26, 95% CI [1.09-1.43], P = 0.001. Bilateral cutdown was also associated with higher wound complications compared to percutaneous access (AOR: 4.41, CI [2.86-6.79], P < 0.001), as was unilateral cutdown (AOR: 3.04, CI [1.46-6.32], P = 0.003). CONCLUSIONS: Patients undergoing cutdown for EVAR are at higher risk for 30-day readmission compared to completely percutaneous access. If patient anatomy allows for percutaneous EVAR, this access option should be prioritized.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Read M, Nguyen T, Swan K, et al. Cutdown is Associated with Higher 30-day Unplanned Readmissions and Wound Complications than Percutaneous Access for EVAR. Ann Vasc Surg. 2024. PMID: 38599484. doi:10.1016/j.avsg.2024.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。